Gilead Sciences Inc at Goldman Sachs Healthcare Conference Transcript
Good afternoon, everyone.Thank you so much for joining us. It's my pleasure to introduce the Gilead team. We have Daniel O'Day, Chairman and Chief Executive Officer, and Andy Dickinson, Chief Financial Officer.
Questions & Answers
To start here, Dan and Andy, perhaps give us an overview of where the company stands today, including your core franchises.And how you're thinking about priorities, outlook, and strategy as we head into the second half of the year and beyond?
' -
Sure. I'll start, and Andy and I can tag team on it. But first of all, thanks for having us here. and we've been talking at this conference for a while now. I would say this is a really important time for Gilead.
It's really just watching our strategy play out over the past seven years. And what that means is kind of consistent commercial clinical execution. And where we have the most robust pipeline
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
